• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY CMW - 9610921 SMARTSET GMV 40G US EO; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY CMW - 9610921 SMARTSET GMV 40G US EO; BONE CEMENT : BONE CEMENT Back to Search Results
Model Number 5450-50-501
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Muscular Rigidity (1968); Pain (1994); Loss of Range of Motion (2032); Ambulation Difficulties (2544); Joint Laxity (4526); Swelling/ Edema (4577)
Event Date 12/05/2017
Event Type  Injury  
Manufacturer Narrative
Product complaint #: (b)(4).Initial reporter occupation: lawyer.Dmf# - (b)(4), trade name gentamicin sulphate, active ingredient(s) gentamicin sulphate, dosage form - powder, strength 1.0g active in our cements.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Patient received a left attune total knee to treat osteoarthritis.The patella was resurfaced and depuy cement x 2 was utilized.There were no indicated intra-operative complications.Patient received a left knee revision to address pain, instability, walking difficulty, swelling, effusion, stiffness, decreased range of motion, tibial tray mispositioning, and tibial tray loosening at the cement to implant interface.The surgeon noted a aori type iia defect on the tibia.The tibial insert, tibial tray, and femoral component were revised.The patellar component was retained.The patient was revised with competitor products.There were no indicated intra-operative complications.Doi: (b)(6) 2016, dor: (b)(6) 2017, left knee.
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.Based on previous investigations, this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Device history lot: a device history record (dhr) review conducted previously on legacy complaint (b)(4), per (b)(4), found two unrelated non conformances on this batch.Micro and sterility tests passed.Corrected: d3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTSET GMV 40G US EO
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY CMW - 9610921
cornford rd.
blackpool IN FY4 4 QQ
UK  FY4 4QQ
MDR Report Key11446622
MDR Text Key238843686
Report Number1818910-2021-04760
Device Sequence Number1
Product Code MBB
UDI-Device Identifier10603295174295
UDI-Public10603295174295
Combination Product (y/n)Y
PMA/PMN Number
K081163
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 02/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2017
Device Model Number5450-50-501
Device Catalogue Number545050501
Device Lot Number8068693
Was Device Available for Evaluation? No
Date Manufacturer Received04/08/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATTUNE MEDIAL ANAT PAT 38MM; ATTUNE PS FEM LT SZ 7 CEM; ATTUNE PS RP INSRT SZ7 6MM; ATTUNE RP TIB BASE SZ 7 CEM; SMARTSET GMV 40G US EO; SMARTSET GMV 40G US EO
Patient Outcome(s) Required Intervention;
Patient Age61 YR
-
-